Work

Abstract #1219 Open-Label Phase 2 Study to Assess Safety and Efficacy Of Relacorilant (Cort125134), A Selective Cortisol Modulator, in the Treatment of Endogenous Hypercortisolism

Year: 2018

Type: conference-abstract

Source: Endocrine Practice

DOI: 10.1016/s1530-891x(20)47511-1

Authors: Andreas Moraitis, Nidhi Agrawal, Irina Bancos, Francesco Celi, Murray Gordon, Atil Kargi, Sam Lerman, Cary Mariash, Julie Silverstein, Margaret Wierman

Language: English

Topic: Adrenal Hormones and Disorders

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3116682345

Cites:

Cited by: 5

Related to: 10